- Azoospermia is the complete absence of sperm in the ejaculate, confirmed on at least two centrifuged semen samples; it affects about 1% of all men and 10-15% of men evaluated for infertility.
- It splits into two very different conditions: obstructive azoospermia (sperm are made but blocked) and non-obstructive azoospermia (the testes make little or no sperm), which are worked up and treated differently.
- Diagnosis combines two centrifuged semen analyses, hormonal labs (FSH, LH, testosterone), physical exam, scrotal ultrasound, and genetic testing (karyotype, Y-chromosome microdeletion, and CFTR when relevant).
- Many men with azoospermia can still father biological children: obstructive cases often respond to surgical reconstruction or sperm aspiration, and non-obstructive cases use microdissection TESE with IVF/ICSI.
- Per the AUA/ASRM guideline, microdissection TESE (micro-TESE) is the recommended retrieval method for non-obstructive azoospermia, with pooled sperm-retrieval rates around 50% versus roughly 35% for conventional TESE.
- This is general education, not medical advice; a confirmed diagnosis warrants referral to a urologist with male-infertility and microsurgical expertise, and couples should be evaluated together.
About 1 percent of all men, and roughly 10 to 15 percent of men evaluated for infertility, have no detectable sperm in their ejaculate. Azoospermia is the complete absence of sperm in semen, confirmed on at least two centrifuged samples. The word sounds final, but the diagnosis rarely is. Modern microsurgery and assisted reproduction allow many men with azoospermia to father biological children, even when they cannot produce sperm in any quantity that would allow natural conception. This article is general education, not medical advice; a confirmed diagnosis calls for a specialist who does this work regularly. For related topics, see our medical conditions library.
Two Fundamentally Different Conditions
Azoospermia divides into obstructive (OA) and non-obstructive (NOA) categories, and the workup, prognosis, and treatment differ substantially between them. Obstructive azoospermia means the testes produce sperm normally, but a blockage somewhere along the reproductive tract prevents sperm from reaching the ejaculate. Non-obstructive azoospermia means the testes themselves produce little or no sperm. Broadly, most azoospermia is non-obstructive and a minority is obstructive, though the exact split varies by the population studied.
Distinguishing the two starts with hormonal labs and a physical exam. According to the AUA/ASRM male infertility guideline (originally published in 2020 and amended in 2024), obstructive azoospermia typically shows normal testicular volume and normal or near-normal FSH, while non-obstructive azoospermia more often shows small testes and elevated FSH. These patterns are general tendencies rather than hard rules, and no single value is diagnostic on its own — which is exactly why a specialist interprets them alongside the exam and imaging.
Causes of Obstructive Azoospermia
The classic cause is prior vasectomy, performed for hundreds of thousands of men each year. Surgical reversal restores patency in a large share of cases, with the odds depending heavily on time elapsed since the vasectomy and on surgical technique. Congenital bilateral absence of the vas deferens (CBAVD) accounts for a small percentage of male infertility and is associated with CFTR gene mutations — the same gene involved in cystic fibrosis — which is why CFTR testing matters when the vas cannot be felt on exam. Other causes include prior epididymitis, complications of hernia repair, ejaculatory duct obstruction, and prior pelvic or retroperitoneal surgery.
Causes of Non-Obstructive Azoospermia
Genetic causes lead the list. Klinefelter syndrome (47,XXY), present in roughly 1 in 500 to 1 in 1,000 men, is the single most common genetic cause of azoospermia. Y-chromosome microdeletions, particularly in the AZFa, AZFb, and AZFc regions, account for a meaningful additional share. AZFa and AZFb deletions typically yield no sperm at all on testicular sampling, while AZFc deletions sometimes permit limited sperm production, which is one reason genetic testing changes the plan.
Acquired causes include prior chemotherapy (alkylating agents are particularly damaging to sperm production), pelvic radiation, orchitis after mumps, severe testicular trauma, undescended testes (especially when corrected late), and exogenous testosterone or anabolic-steroid use. Notably, testosterone replacement suppresses the body’s own sperm production and is a common, sometimes reversible, contributor. Hypogonadotropic hypogonadism from pituitary or hypothalamic disease also produces azoospermia, and this form is often reversible with hormonal treatment.
Diagnosis
Two centrifuged semen analyses, spaced at least a few weeks apart, confirm the diagnosis. Our semen analysis guide covers how samples should be collected and processed; centrifugation is critical because some men with extremely low counts (cryptozoospermia) have isolated sperm visible only after the sample is spun down, which can change management entirely. A post-ejaculation urine analysis helps rule out retrograde ejaculation, particularly when semen volume is low.
Hormonal evaluation includes total testosterone, FSH, and LH, with prolactin and sometimes estradiol added based on the picture. The physical exam assesses testicular size and consistency, palpates for the presence of the vas deferens (absent in CBAVD), and looks for a varicocele. Scrotal ultrasound visualizes testicular architecture, masses, and signs of obstruction, and transrectal ultrasound evaluates the ejaculatory ducts when distal obstruction is suspected.
Genetic testing — karyotype and Y-chromosome microdeletion analysis — is recommended for non-obstructive azoospermia and severe oligospermia, and CFTR mutation analysis is added when CBAVD is suspected. The medical conditions library includes related topics such as varicocele and low sperm count.
Treatment
Obstructive Azoospermia
Surgical reconstruction is often feasible. Vasovasostomy (vas-to-vas reconnection) and vasoepididymostomy (vas-to-epididymis) restore patency in many post-vasectomy and other obstructive cases. When reconstruction is not feasible or not chosen, microsurgical sperm aspiration from the epididymis (MESA) or extraction from the testis collects sperm directly for in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). Ejaculatory duct obstruction can be treated with transurethral resection of the ejaculatory ducts (TURED). Because sperm production is usually normal in obstructive cases, the outlook for building a family is generally favorable.
Non-Obstructive Azoospermia
Hormonal treatment is reserved for the subset with hypogonadotropic hypogonadism, where medications such as clomiphene, hCG, and FSH can restore sperm production over months. For most non-obstructive cases, microdissection testicular sperm extraction (micro-TESE) is the treatment of choice. The AUA/ASRM guideline recommends micro-TESE over conventional TESE for non-obstructive azoospermia: in a pooled analysis of studies comparing the two techniques, sperm-retrieval rates were roughly 52 percent for micro-TESE versus about 35 percent for conventional TESE. Retrieval rates vary widely by the underlying cause — often more favorable in Klinefelter syndrome and AZFc microdeletion, and essentially zero in AZFa and AZFb microdeletions. These figures are averages across studies and are not a prediction for any one person.
Retrieved sperm are used immediately or cryopreserved for IVF with ICSI. Because ICSI injects a single sperm directly into an egg, even a very small number of viable sperm can be enough.
Donor Sperm and Adoption
For men with AZFa or AZFb deletions, or after repeatedly unsuccessful micro-TESE, donor sperm insemination or adoption remain paths to parenthood. These are significant decisions best supported by a fertility counselor and, where relevant, a genetic counselor.
When to See a Doctor
Any man with a confirmed absence of sperm on two semen analyses should see a urologist with specific male-infertility and microsurgical expertise, not simply a general urologist. Surgical technique and pre-operative evaluation meaningfully affect outcomes, and micro-TESE in particular is operator-dependent. Couples should be evaluated together, since female fertility factors and timing shape the overall plan. Our male infertility guide covers the couple-level workup.
When to seek emergency care: Call 911 or go to the nearest emergency room for sudden severe testicular pain (testicular torsion is a surgical emergency measured in hours), acute scrotal swelling with redness or fever, or sudden severe scrotal swelling after recent surgery.
Frequently Asked Questions
Can a man with azoospermia father children?
In many cases, yes. Obstructive azoospermia often responds to surgical reconstruction or sperm retrieval. Non-obstructive azoospermia has meaningful sperm-retrieval rates with micro-TESE (roughly half on average, though it varies by cause), and any retrieved sperm can be used with IVF/ICSI.
Does Klinefelter syndrome always cause azoospermia?
Most adult men with classic Klinefelter syndrome have azoospermia, but micro-TESE recovers sperm in a substantial share of cases, and ICSI with retrieved sperm has produced many healthy children worldwide.
Will my children inherit my fertility issue?
Some causes are heritable. Y-chromosome microdeletions pass to male offspring, and CFTR mutations can affect both sons and daughters. Genetic counseling helps couples weigh their options, including preimplantation genetic testing.
How long should I stop testosterone before fertility testing?
Reproductive urologists commonly ask men to stop exogenous testosterone for several months, sometimes longer, before final fertility decisions, because testosterone suppresses the body’s own sperm production. Recovery is incomplete in some men, but many regain sperm production over time. Do not stop or change any prescription on your own — coordinate it with the prescriber.
What to Do Next
An azoospermia diagnosis is the start of a focused workup, not an endpoint. The first move is two confirmatory centrifuged semen analyses, followed by hormonal labs, a physical exam, scrotal ultrasound, and genetic testing in non-obstructive cases. From there, treatment paths diverge sharply between obstructive and non-obstructive disease, and outcomes depend heavily on choosing a urologist who performs micro-TESE and microsurgical reconstruction regularly. Many men who are told they cannot biologically father children receive that message too soon — and before a specialist has finished the evaluation.
This article is general education and is not medical advice. Azoospermia has many causes with very different treatments and outcomes, and figures such as retrieval rates are averages, not predictions for any individual. See a urologist with male-infertility and microsurgical expertise for diagnosis and a plan, and have both partners evaluated together.
For more plain-language explainers on men’s health and fertility, see our medical conditions library and male infertility guide.
Sources
- AUA/ASRM — Diagnosis and Treatment of Infertility in Men: Guideline (2020; amended 2024), including the micro-TESE recommendation and pooled sperm-retrieval data
- American Society for Reproductive Medicine (ASRM) — male infertility practice documents
- MedlinePlus (U.S. National Library of Medicine) — male infertility and azoospermia overview
- Cleveland Clinic — Azoospermia: causes, diagnosis, and treatment (patient information)
- Peer-reviewed comparisons of microdissection TESE versus conventional TESE for non-obstructive azoospermia